Wikipedia -WSS

Wikipedia

author：explore 2025-09-27 12:56:08 - browse：1681

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Flagship Pioneering launches a new biotech in two countries

Wikipedia

WSS

HIV drugs protect against transmission, even in unprotected sex

Woman returns to dialysis after doctors remove transplanted pig kidney

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Mayo Clinic plans $5B tech

HIV drugs protect against transmission, even in unprotected sex

focus

Wikipedia

explore

In age of alternative facts, a scholarly course on calling out crap

U.K. Biobank has 500,000 peoples' genome sequences available

Drug repurposing or repositioning? The language matters

ReNAgade cuts staff seven months after raising $300 million

Alkermes shareholders re

Ultragenyx gene therapy for rare liver ailment succeeds in late

Cancer drug shortages should be causing more outrage

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Duchenne breakthrough therapy leaves behind pioneering families

Will the market for weight loss drugs really reach $100 billion?

focus

What don’t we know about an Alzheimer’s drug side effect?

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Will the market for weight loss drugs really reach $100 billion?

BMI, flaws aside, is found to be useful estimate of body fat in youth

The Pandemic Treaty must support building strong health systems

UnitedHealth’s Optum accused of antitrust violations in California

hotspot

hotspot

Wikipedia

focus